Sequential fluorescence in situ hybridization for the quantification of minimal residual disease in recipient cells after sex-mismatched allogeneic stem cell transplantation.
BMT Unit, Department Of Oncology, Gregorio Marañón G. U. Hospital, Madrid, Spain. ibuno@hotmail.com
Ismael
I
Buño
Elena
E
Moreno-Lopez
Jose Luis
JL
Diez-Martin
D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis; D012008:Recurrence; D018183:Transplantation Chimera; D014184:Transplantation, Homologous